Literature DB >> 22482833

Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion.

Jaap J Kloek1, Xavier Maréchal, Jeroen Roelofsen, Riekelt H Houtkooper, André B P van Kuilenburg, Willem Kulik, Rick Bezemer, Rémi Nevière, Thomas M van Gulik, Michal Heger.   

Abstract

AIMS: The aim was to investigate the impact of ischemia-reperfusion (I/R) on intrahepatic oxidative stress, oxidative phosphorylation, and nucleotide metabolism in relation to liver damage and inflammation in cholestatic rats to elucidate the molecular mechanisms responsible for post-I/R pathogenesis during cholestasis.
RESULTS: Pre-I/R cholestatic livers exhibited mild hepatopathology in the form of oxidative/nitrosative stress, perfusion defects, necrosis and apoptosis, inflammation, and fibrosis. Plasma bilirubin concentration in cholestatic livers was 190 μM. I/R in cholestatic livers exacerbated hepatocellular damage and leukocyte infiltration. However, myeloperoxidase activity in neutrophils at 6 h reperfusion was not elevated in cholestatic livers compared to pre-I/R levels and to control (Ctrl) livers. At 6 h reperfusion, cholestatic livers exhibited severe histological damage, which was absent in Ctrl livers. Despite a lower antioxidative capacity after I/R, no cardiolipin peroxidation and equivalent reduced glutathione/oxidized glutathione ratios and Hsp70 levels were found in cholestatic livers versus Ctrls. Bilirubin acted as a potent and protective antioxidant. Postischemic resumption of oxidative phosphorylation in Ctrl livers proceeded rapidly and encompassed reactive hyperemia, which was significantly impaired in cholestatic livers owing to extensive vasoconstriction and perfusion defects. Normalization of intrahepatic energy status and nucleotide-based metabolic cofactors was delayed in cholestatic livers during reperfusion. Innovation and
CONCLUSIONS: Cholestatic livers possess sufficient antioxidative capacity to ameliorate radical-mediated damage during I/R. I/R-induced damage in cholestatic livers is predominantly caused by microvascular perfusion defects rather than exuberant oxidative/nitrosative stress. The forestalled rate of oxidative phophorylation and recovery of bioenergetic and possibly metabolic parameters during the early reperfusion phase are responsible for extensive liver damage.

Entities:  

Mesh:

Year:  2012        PMID: 22482833     DOI: 10.1089/ars.2011.4291

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  23 in total

Review 1.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

2.  Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Authors:  Mohammad Nasehi; Sepehr Torabinejad; Mehrdad Hashemi; Salar Vaseghi; Mohammad-Reza Zarrindast
Journal:  Metab Brain Dis       Date:  2019-11-26       Impact factor: 3.584

Review 3.  The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury.

Authors:  Rowan F van Golen; Megan J Reiniers; Nienke Vrisekoop; Coert J Zuurbier; Pim B Olthof; Jacco van Rheenen; Thomas M van Gulik; Barry J Parsons; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

4.  Peritransplant Energy Changes and Their Correlation to Outcome After Human Liver Transplantation.

Authors:  Bote G Bruinsma; James H Avruch; Gautham V Sridharan; Pepijn D Weeder; Marie Louise Jacobs; Kerry Crisalli; Beth Amundsen; Robert J Porte; James F Markmann; Korkut Uygun; Heidi Yeh
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

Review 5.  Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Authors:  Daniel J de Klerk; Mark J de Keijzer; Lionel M Dias; Jordi Heemskerk; Lianne R de Haan; Tony G Kleijn; Leonardo P Franchi; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

6.  Optimal Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes.

Authors:  Megan J Reiniers; Lianne R de Haan; Laurens F Reeskamp; Mans Broekgaarden; Ruurdtje Hoekstra; Rowan F van Golen; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

8.  Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice.

Authors:  Heping Yang; Tony W H Li; Yu Zhou; Hui Peng; Ting Liu; Ebrahim Zandi; María Luz Martínez-Chantar; José M Mato; Shelly C Lu
Journal:  Antioxid Redox Signal       Date:  2014-10-17       Impact factor: 8.401

9.  Protective Mechanisms of Hypothermia in Liver Surgery and Transplantation.

Authors:  Pim B Olthof; Megan J Reiniers; Marcel C Dirkes; Thomas M van Gulik; Rowan F van Golen
Journal:  Mol Med       Date:  2015-11-03       Impact factor: 6.354

10.  Analysis and Optimization of Conditions for the Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes.

Authors:  Megan J Reiniers; Lianne R de Haan; Laurens F Reeskamp; Mans Broekgaarden; Rowan F van Golen; Michal Heger
Journal:  Antioxidants (Basel)       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.